Skip to main content

Table 2 Summary of paclitaxel, ifosfamide, carboplatin, and etoposide therapy cycles given to our patient

From: Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report

Cycles

Frequency

Days

1–2

Every 14 days

D 1: paclitaxel 250 mg/m2 IV over 24 hours

D 2–4: ifosfamide 2000 mg/m2 IV + mesna support

D 4–14: GCSF 10 mcg/kg per day

D 11–14: stem cell collection (28×106/kg CD34+ cells collected)

3–5

Every 21 days

D 1–3: carboplatin AUC = 8 IV + etoposide 400 mg/m2 IV

D 5: stem cell infusion (9.65×106/kg CD34+ cells with each cycle)

D 3–21: GCSF 10mcg/kg per day

  1. AUC area under the concentration-time curve, D days, GCSF granulocyte-colony stimulating factor, IV intravenous